Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Safety monitoring and information (133)
- Compliance and enforcement (34)
- Import and export (33)
- Shortages and supply disruptions (15)
- Sunscreens (10)
- Advertising (6)
- COVID-19 (5)
- Weight loss products (5)
- Labelling and packaging (4)
- Breast implant hub (3)
- Manufacturing (3)
- Legislation (2)
- Cosmetics (1)
- Metal-on-metal hip replacement implants hub (1)
Type of content
Search
1301 result(s) found, displaying 1176 to 1200
-
Market actionsThe fat loss capsules were illegally supplied to the market. The prescription-only (S4) medicines Sibutramine and Phenolphthalein were detected in a sample.
-
Safety alertsUpdated web advisory.
-
Safety alertsUpdated web advisory.
-
Safety alertsUrgent web advisory.
-
Market actions
-
Market actionsA number of brands of hot/cold gel packs are being recalled following testing by the Therapeutic Goods Administration (TGA) of contents for ethylene glycol, a toxic substance.
-
Market actionsRecall due to product containing the toxic substance ethylene glycol (rather than the non-toxic ingredient propylene glycol).
-
Market actionsA number of brands of hot/cold gel packs are being recalled following testing by the Therapeutic Goods Administration (TGA) of contents for ethylene glycol, a toxic substance. Testing was undertaken following the previous recall of Thermoskin® hot/cold gel packs to determine if the problem was more widespread.
-
Market actionsThe Therapeutic Goods Administration (TGA) advised on 2 September 2008 that the Thermoskin® brand of hot/cold gel packs was being recalled after testing revealed that they contained the toxic substance ethylene glycol, rather than the non-toxic ingredient propylene glycol.
-
Market actionsRecall due to product containing the toxic substance ethylene glycol (rather than the non-toxic ingredient propylene glycol).
-
-
Market actionsThis product contains the toxic substance ethylene glycol (rather than the non-toxic ingredient propylene glycol).
-
Market actionsThese products contains the toxic substance ethylene glycol (rather than the non-toxic ingredient propylene glycol).
-
Market actionsRecall due to product containing the toxic substance ethylene glycol (rather than the non-toxic ingredient propylene glycol).
-
Market actionsThis product contains the toxic substance ethylene glycol (rather than the non-toxic ingredient propylene glycol).
-
Market actionsRecall due to products containing the toxic substance ethylene glycol (rather than the non-toxic ingredient propylene glycol).
-
Market actionsRecall letters will be dispatched by the sponsor to pharmacies from Tuesday 16 September 2008.
-
Safety alerts
-
Market actionsThis product contains the toxic substance ethylene glycol (rather than the non-toxic ingredient propylene glycol).
-
Safety alertsRecall of Thermoskin® brand gel hot/cold packs after testing revealed that the packs contain the toxic substance ethylene glycol, rather than the non-toxic ingredient propylene glycol.
-
Market actions
-
Market actionsClexane (enoxaparin) is being recalled due to contamination concerns, and patients should check with their doctor or pharmacist to see if their supply is affected.
-
Market actionsConsumers should stop using Clexane (enoxaparin) from the newly recalled batch due to impurity concerns. Check with your doctor or pharmacist to see if your supply is affected and return any contaminated product. If you have any concerns, consult your doctor.
-
Safety alertsThe TGA has been informed by the supplier of Clexane, sanofi-aventis Australia, that this recall applies to one batch of Clexane 80mg, with batch number 08018.
-
Safety alertsScreening guidelines for women exposed in utero to diethylstilboestrol (DES)